| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 05/29/2013 | EP2597089A1 Tricyclic heterocyclic compounds |
| 05/29/2013 | EP2596793A1 Quinoline derivatives as PI3 kinase inhibitors |
| 05/29/2013 | EP2595995A1 Herbicidal isoxazolo[5,4-b]pyridines |
| 05/29/2013 | EP2595994A2 Process for preparing pyrano - [2,3-c]pyridine derivatives |
| 05/29/2013 | EP2595989A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
| 05/29/2013 | EP2595987A1 New aminopyrazoloquinazolines |
| 05/29/2013 | EP2595983A1 2,3,5-trisubstituted thiophene compounds and uses thereof |
| 05/29/2013 | CN103124733A Herbicidal isoxazolo[5,4-b]pyridines |
| 05/28/2013 | US8450343 Gamma secretase modulators |
| 05/28/2013 | US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors |
| 05/28/2013 | US8450340 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 05/28/2013 | US8450333 Molecules for regulating cell death |
| 05/28/2013 | US8450307 Therapeutic agents, and methods of making and using the same |
| 05/28/2013 | CA2584651C Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 05/28/2013 | CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia |
| 05/23/2013 | WO2013072903A1 Nitroimidazoxadiazocine compounds |
| 05/23/2013 | WO2013072703A1 Antibacterial drug derivatives |
| 05/23/2013 | WO2013071697A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/23/2013 | US20130131091 Harmful organism control agent |
| 05/23/2013 | US20130131064 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands |
| 05/23/2013 | US20130131055 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof |
| 05/23/2013 | US20130131042 Spiroxazolidinone compounds |
| 05/23/2013 | US20130131041 Spirocyclic compounds |
| 05/23/2013 | US20130131039 5,7-substituted-imidazo[1,2-c]pyrimidines as inhibitors of jak kinases |
| 05/23/2013 | US20130131018 Substituted isoquinolines and their use as tubulin polymerization inhibitors |
| 05/23/2013 | CA2851151A1 Aminoquinazoline derivatives and their salts and methods of use |
| 05/22/2013 | EP2593463A1 Formulations of rifaximin and uses thereof |
| 05/22/2013 | EP2593461A1 Compounds for the reduction of beta-amyloid production |
| 05/22/2013 | CN103119028A 1,2,4-Triazolone Derivative |
| 05/22/2013 | CN103113388A Preparation method of levofloxacin |
| 05/22/2013 | CN102137844B Compounds and compositions as modulators of GPR119 activity |
| 05/22/2013 | CN101479250B Tetrazole-substituted arylamides |
| 05/21/2013 | US8445509 Fused heterocyclic derivatives and use thereof |
| 05/21/2013 | US8445484 Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases |
| 05/21/2013 | US8445479 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 05/16/2013 | WO2013071027A1 Macrocyclic compounds for inhibition of inhibitors of apoptosis |
| 05/16/2013 | WO2013070961A1 Modulators of atp-binding cassette transporters |
| 05/16/2013 | WO2013068439A1 4-amino-5-oxo-7,8-dihydropyrimido[5, 4 -f] [1, 4] oxazepine compounds as dgat1 inhibitors |
| 05/16/2013 | WO2013068328A1 Bicyclo [2.2.2] octan-1-ylcarboxylic acid compounds as dgat-1 inhibitors |
| 05/16/2013 | US20130123250 Spiro (piperidine-4,2'-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as nk1 tachikynin receptor antagonists |
| 05/16/2013 | US20130123249 Novel benzoxazine oxazolidinone compounds, preparation methods and uses thereof |
| 05/16/2013 | US20130123217 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits |
| 05/16/2013 | US20130123105 Herbicidal Isoxazolo[5,4-B]pyridines |
| 05/16/2013 | CA2852991A1 Modulators of atp-binding cassette transporters |
| 05/15/2013 | EP2592070A2 Tetrazole-substituted arylamides |
| 05/15/2013 | EP2590985A1 Novel spiroheterocyclic compounds as mglu5 antagonists |
| 05/15/2013 | EP2590980A1 Fused heterocyclic derivatives as s1p modulators |
| 05/15/2013 | CN103108878A Derivatives of 6, 7-dihydro-3h-oxazolo [3, 4-a] pyrazine-5, 8- dione |
| 05/15/2013 | CN103102348A Oxadiazole compound and preparation method thereof, medicine composition and application thereof |
| 05/15/2013 | CN103102344A Aminoquinazoline derivative, salts thereof and application method |
| 05/15/2013 | CN102046639B New classes of GABAA/BzR ligands |
| 05/15/2013 | CN101331138B One pot synthesis of tetrazole derivatives of sirolimus |
| 05/14/2013 | US8440685 Method for treatment of neurologic dysfunction |
| 05/14/2013 | CA2723014C A herbicidal composition comprising a 3-hydroxy-4-aryl-5-oxopyrazoline derivative and an isoxadifen derivative |
| 05/14/2013 | CA2547343C Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| 05/10/2013 | WO2013067264A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity |
| 05/10/2013 | WO2013067248A1 Benzoxazines as modulators of ion channels |
| 05/10/2013 | WO2013064519A1 Pesticidal compounds |
| 05/10/2013 | WO2012112548A3 Firmocidin, an antimicrobial molecule produced by staphylococcus epidermidis |
| 05/10/2013 | CA2853967A1 8-fluorophthalazin-1 (2h) -one compounds as inhibitors of btk activity |
| 05/09/2013 | US20130116246 8-fluorophthalazin-1(2h)-one compounds |
| 05/09/2013 | US20130116245 Alkylated piperazine compounds |
| 05/09/2013 | US20130116243 Inhibitors of akt activity |
| 05/09/2013 | US20130116237 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 05/09/2013 | US20130116235 Heteroaryl pyridone and aza-pyridone compounds |
| 05/08/2013 | EP2589595A1 Agent for treating hcv infection |
| 05/08/2013 | EP2588451A1 Piperidine derivatives and their use for the treatment of metabolic disorders |
| 05/08/2013 | CN103097392A Carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 05/08/2013 | CN103097391A Novel spiroheterocyclic compounds as mGlu5 antagonists |
| 05/08/2013 | CN103097388A New aminopyrazoloquinazolines |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/07/2013 | US8436028 CETP inhibitors derived from benzoxazole arylamides |
| 05/07/2013 | US8436010 Treatment of solid tumors with rapamycin derivatives |
| 05/07/2013 | US8435528 Cytotoxic agents comprising new maytansinoids |
| 05/07/2013 | CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/02/2013 | WO2013063217A1 Fused bicyclic oxazolidinone cetp inhibitor |
| 05/02/2013 | WO2013062858A1 Isoxazolopyridine orexin receptor antagonists |
| 05/02/2013 | WO2013062079A1 Dihydroimidazooxazole derivative |
| 05/02/2013 | WO2013062027A1 Azole derivative |
| 05/02/2013 | WO2013061962A1 Bicyclic compound |
| 05/02/2013 | WO2013060258A1 Clavatine a-c, preparation method thereof and pharmaceutical composition and use thereof |
| 05/02/2013 | WO2013036053A3 Solid dispersion comprising tacrolimus and method for preparing the same |
| 05/02/2013 | US20130109670 Triazine compounds as pi3 kinase and mtor inhibitors |
| 05/02/2013 | US20130109649 Fused bicyclic oxazolidinone cetp inhibitor |
| 05/02/2013 | CA2853227A1 Azole derivative |
| 05/02/2013 | CA2853221A1 Bicyclic compound |
| 05/02/2013 | CA2852743A1 Fused bicyclic oxazolidinone cetp inhibitor |
| 05/01/2013 | EP2585462A1 Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors |
| 05/01/2013 | CN103080087A Piperidine derivatives and their use for the treatment of metabolic disorders |
| 05/01/2013 | CN103079566A Heterocyclyl compounds as histamine H3 receptor ligands |
| 05/01/2013 | CN102015711B Spiro-indole derivatives for the treatment of parasitic diseases |
| 05/01/2013 | CN101657430B Organic compounds and their uses |
| 04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/30/2013 | US8431564 Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/24/2013 | EP2583971A1 Method for producing carbodiimide |
| 04/24/2013 | EP2583966A2 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases |
| 04/24/2013 | EP2583960A1 Process for production of intermediate for cyclic carbodiimide compound |
| 04/24/2013 | EP2583720A1 Oxazolopyrimidines as Edg-1 receptor agonists |
| 04/24/2013 | EP2582707A2 Polymorphic forms of rifaximin |